Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2003-10-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0960-894X(03)00755-8PMID 14505683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization.

  2002cited by this paper
• Structure-based design of nonpeptide inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1).

  2002cited by this paper
• Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury*

  2002cited by this paper
• Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design.

  2002cited by this paper
• Potent and selective nonpeptide inhibitors of caspases 3 and 7.

  2001cited by this paper
• Metabolism of fluorine-containing drugs.

  2001cited by this paper
• Structure-based design of caspase-1 inhibitor containing a diphenyl ether sulfonamide.

  2001cited by this paper
• N-nitrosoanilines: a new class of caspase-3 inhibitors.

  2001cited by this paper
• Long‐term protection of brain tissue from cerebral ischemia by peripherally administered peptidomimetic caspase inhibitors

  2001cited by this paper
• Caspases: recent advances in small molecule inhibitors

  2001cited by this paper
• The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family.

  2000cited by this paper
• Caspases as targets for anti-inflammatory and anti-apoptotic drug discovery.

  2000cited by this paper
• Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8.

  2000cited by this paper
• Irreversible caspase inhibitors: tools for studying apoptosis.

  1999cited by this paper
• Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1.

  1997cited by this paper
• The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers.

  1997cited by this paper
• The effects of dexamethasone and chlorpromazine on tumour necrosis factor‐α, interleukin‐1β, interleukin‐1 receptor antagonist and interleukin‐10 in human volunteers

  1997cited by this paper
• Active Site Amino Acids That Participate in the Catalytic Mechanism of Nucleoside 2′-Deoxyribosyltransferase (*)

  1996cited by this paper
• Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors*

  1996cited by this paper
• Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases.

  1995cited by this paper
• P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1 beta-converting enzyme.

  1994cited by this paper
• Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones.

  1994cited by this paper
• In vivo inhibition of cathepsin B by peptidyl (acyloxy)methyl ketones.

  1994cited by this paper
• Prevention of vertebrate neuronal death by the crmA gene.

  1994cited by this paper
• Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

  1993cited by this paper
• Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3

  1993cited by this paper
• Cell death studies yield cancer clues.

  1993cited by this paper
• Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases.

  1991cited by this paper

• Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH )

  2021cites this paper
• The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.

  2020cites this paper
• Tunable Probes with Direct Fluorescence Signals for the Constitutive and Immunoproteasome.

  2016cites this paper
• Regulierbare Sonden mit direktem Fluoreszenzsignal für das konstitutive und das Immunoproteasom

  2016cites this paper
• Pharmacological caspase inhibitors: research towards therapeutic perspectives.

  2015cites this paper
• Small Molecule Active Site Directed Tools for Studying Human Caspases.

  2015cites this paper
• Cell death targets and potential modulators in Alzheimer's disease.

  2010cites this paper
• The potential for caspases in drug discovery.

  2010cites this paper
• Synthesis and structure-activity relationships of oxamyl dipeptide caspase inhibitors developed for the treatment of liver disease.

  2009cites this paper
• Synthesis of 4-amino-thiazole analogs of Fmoc-amino acids and thiazole linked N-orthogonally protected dipeptidomimetics.

  2009cites this paper
• Screening for Caspase-3 Inhibitors: A New Class of Potent Small-Molecule Inhibitors of Caspase-3

  2006cites this paper
• Alpha-aminoalkyl-alpha'-halomethylketones: Preparation and application to pharmaceutically interesting compounds.

  2006cites this paper
• Thiol proteases: inhibitors and potential therapeutic targets.

  2006cites this paper
• Design, synthesis, and evaluation of cysteine protease inhibitors.

  2005cites this paper
• Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads.

  2005cites this paper
• XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs

  2005cites this paper
• First-in-class pan caspase inhibitor developed for the treatment of liver disease.

  2005cites this paper
• DESIGN, SYNTHESIS, AND EVALUATION OF CYSTEINE

  2005cites this paper
• Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid.

  2004cites this paper
• Solid phase synthesis of selective caspase-3 peptide inhibitors.

  2004cites this paper
• Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.

  2004cites this paper
• Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.

  2004cites this paper
• Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group.

  2004cites this paper